Wedbush Securities’s Enlivex Therapeutics ENLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-938
| Closed | -$25K | – | 849 |
|
|
2017
Q2 | $25K | Buy |
938
+563
| +150% | +$15K | ﹤0.01% | 822 |
|
|
2017
Q1 | $11K | Buy |
+375
| New | +$11K | ﹤0.01% | 833 |
|
|
2016
Q4 | – | Sell |
-525
| Closed | -$36K | – | 836 |
|
|
2016
Q3 | $36K | Buy |
525
+100
| +24% | +$6.86K | 0.01% | 803 |
|
|
2016
Q2 | $27K | Buy |
+425
| New | +$27K | ﹤0.01% | 756 |
|